Cited In for PMID: 16322205

Year	Number of Results
2005	1
2009	2
2010	2
2011	1
2012	1
2013	2
2015	2
2016	2
2017	2
2018	1
2019	1
2020	1
2021	1
2026	0

1

Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides.

Snyder EL, Saenz CC, Denicourt C, Meade BR, Cui XS, Kaplan IM, Dowdy SF. Snyder EL, et al. Cancer Res. 2005 Dec 1;65(23):10646-50. doi: 10.1158/0008-5472.CAN-05-0118. Cancer Res. 2005. PMID: 16322205

2

Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?

Zhao CX, Zeng CM, Wang K, He QJ, Yang B, Zhou FF, Zhu H. Zhao CX, et al. Acta Pharmacol Sin. 2021 Feb;42(2):179-188. doi: 10.1038/s41401-020-0441-3. Epub 2020 Jun 29. Acta Pharmacol Sin. 2021. PMID: 32601365 Free PMC article. Review.

3

Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery.

Heon Lee I, Palombo MS, Zhang X, Szekely Z, Sinko PJ. Heon Lee I, et al. Eur J Pharm Biopharm. 2019 May;138:11-22. doi: 10.1016/j.ejpb.2018.06.004. Epub 2018 Jun 9. Eur J Pharm Biopharm. 2019. PMID: 29894816 Free PMC article.

4

Endolysosomal targeting of a clinical chlorin photosensitiser for light-triggered delivery of nano-sized medicines.

Yaghini E, Dondi R, Tewari KM, Loizidou M, Eggleston IM, MacRobert AJ. Yaghini E, et al. Sci Rep. 2017 Jul 20;7(1):6059. doi: 10.1038/s41598-017-06109-y. Sci Rep. 2017. PMID: 28729656 Free PMC article.

5

Building Cell Selectivity into CPP-Mediated Strategies.

Martín I, Teixidó M, Giralt E. Martín I, et al. Pharmaceuticals (Basel). 2010 May 14;3(5):1456-1490. doi: 10.3390/ph3051456. Pharmaceuticals (Basel). 2010. PMID: 27713313 Free PMC article. Review.

6

Functional peptides for siRNA delivery.

Tai W, Gao X. Tai W, et al. Adv Drug Deliv Rev. 2017 Feb;110-111:157-168. doi: 10.1016/j.addr.2016.08.004. Epub 2016 Aug 13. Adv Drug Deliv Rev. 2017. PMID: 27530388 Free PMC article. Review.

7

Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.

Wang Y, Xie Y, Oupický D. Wang Y, et al. Curr Pharmacol Rep. 2016 Feb;2(1):1-10. doi: 10.1007/s40495-015-0044-8. Epub 2016 Jan 4. Curr Pharmacol Rep. 2016. PMID: 27088072 Free PMC article.

8

Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.

Liang AL, Qian HL, Zhang TT, Zhou N, Wang HJ, Men XT, Qi W, Zhang PP, Fu M, Liang X, Lin C, Liu YJ. Liang AL, et al. Drug Des Devel Ther. 2015 Oct 16;9:5671-86. doi: 10.2147/DDDT.S90082. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26527862 Free PMC article.

9

siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells.

Li H, He J, Yi H, Xiang G, Chen K, Fu B, Yang Y, Chen G. Li H, et al. Biosci Rep. 2015 Mar 18;35(2):e00181. doi: 10.1042/BSR20140145. Biosci Rep. 2015. PMID: 25671640 Free PMC article.

10

Applications of cell-penetrating peptides for tumor targeting and future cancer therapies.

Regberg J, Srimanee A, Langel U. Regberg J, et al. Pharmaceuticals (Basel). 2012 Sep 12;5(9):991-1007. doi: 10.3390/ph5090991. Pharmaceuticals (Basel). 2012. PMID: 24280701 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 16322205

16 results

Results by year